NA
GOSS icon

Neuburgh Advisers’s Gossamer Bio GOSS Stock Holding History

Neuburgh Advisers’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$708K Buy
527
+307
+140% +$488K 0.02% 388
2019
Q2 		$390K Sell
220
-34
-13% -$52K 0.01% 519
2019
Q1 		$441K Buy
+254
New +$424K 0.02% 481

Other funds holding GOSS

OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Neuburgh Advisers's GOSS Position: Q3 2019 in Review

Neuburgh Advisers increased its Gossamer Bio (GOSS) stake by 140% in Q3 2019, buying an estimated $488K and bringing the position to 527 shares worth $708K. The position accounts for 0.02% of the portfolio, ranked #388.

Neuburgh Advisers first reported a position in GOSS in Q1 2019 and has held it in 3 quarters since. 78 funds tracked by Wall St. Rank hold GOSS as of Q3 2019.

  • Neuburgh Advisers held 527 shares of Gossamer Bio worth $708K as of Q3 2019.
  • Neuburgh Advisers bought 307 Gossamer Bio shares in Q3 2019, an estimated $488K.
  • Gossamer Bio made up 0.02% of Neuburgh Advisers's portfolio in Q3 2019, its #388 holding.
  • Neuburgh Advisers first reported a position in Gossamer Bio in Q1 2019 and has held it in 3 quarters since.
  • 78 funds tracked by Wall St. Rank held Gossamer Bio as of Q3 2019.

Based on Neuburgh Advisers's 13F filing for Q3 2019, filed 14 Nov 2019.